Antibiotic use was associated with increased risk for some cancers
the ONA take:
Recurrent exposure to antibiotics may increase the risk for cancer in specific organ sites, according to a recent report published in the European Journal of Cancer.
A large population-based electronic medical record database was used to conduct nested case-control studies for 15 common malignancies. Persons with inherited cancer syndromes were excluded. Four eligible matched controls were selected for every case. In total, 125,441 cases and 490,510 matched controls were analyzed.
The findings demonstrated use of penicillin was associated with higher risk of some GI cancers, and this association was higher for those who underwent more antibiotic courses.
Penicillin, cephalosporins, or macrolides use was associated with higher risk for lung cancer; penicillin, quinolones, sulphonamides, and tetracyclines were associated with moderately increased risk for prostate cancer; and sulphonamides were modestly associated with risk for breast cancer. However, no association was found with the use of antivirals and antifungals.
Recurrent exposure to antibiotics may increase the risk for cancer in specific organ sites.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|